MCL1 and cancer: We further validate that splicing modulator induces selective apoptosis in cancer cell lines with endogenous amplification and high expression of MCL1 or BCL2A1, and combination of splicing inhibition and BCLxL (encoded by BCL2L1) inhibition induces a synergistic cytotoxicity in cancer cells.